Acetrizoic Acid

CHEMBL1201327 Phase 4 معتمد Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
556.9 g/mol
LogP
2.6
Phase
4

An iodinated contrast medium used in older radiological imaging to enhance the visibility of internal structures on X-ray examinations. Like other early ionic contrast agents, it carries a higher risk of allergic reactions and discomfort compared to modern low-osmolality contrast agents. It is primarily of historical interest in the development of diagnostic radiology.

الوزن الجزيئي

556,8600 g/mol

LogP

2,60

TPSA

66,40 Ų

قاعدة ليبينسكي للخمسة

ناجح

آلية العمل

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

الآلية

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I

InChI

InChI=1S/C9H6I3NO3/c1-3(14)13-8-5(11)2-4(10)6(7(8)12)9(15)16/h2H,1H3,(H,13,14)(H,15,16)

Molecular Formula

C9H6I3NO3

HBD / HBA

2 / 3

الروابط القابلة للدوران

2

الذرات الثقيلة

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

An iodinated contrast medium used in older radiological imaging to enhance the visibility of internal structures on X-ray examinations. Like other early ionic contrast agents, it carries a higher risk of allergic reactions and discomfort compared to modern low-osmolality contrast agents. It is primarily of historical interest in the development of diagnostic radiology.

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Yes, Acetrizoic Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201327. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6806. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.